# Effects of Anti-TSLP in Patients With Asthma

> **NCT02698501** · PHASE2 · COMPLETED · sponsor: **Celeste Porsbjerg** · enrollment: 40 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** MEDI9929
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02698501
- **Lead sponsor:** Celeste Porsbjerg
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08
- **Primary completion:** 2019-08-07
- **Final completion:** 2019-10-07
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2021-06-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02698501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02698501, "Effects of Anti-TSLP in Patients With Asthma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02698501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*